Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).

Modde F, Agustian PA, Wittig J, Dämmrich ME, Forstmeier V, Vester U, Ahlenstiel T, Froede K, Budde U, Wingen AM, Schwarz A, Lovric S, Kielstein JT, Bergmann C, Bachmann N, Nagel M, Kreipe HH, Bröcker V, Bockmeyer CL, Becker JU.

Virchows Arch. 2013 Apr;462(4):455-64. doi: 10.1007/s00428-013-1386-4. Epub 2013 Mar 9.

PMID:
23475501
2.

Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy.

Agustian PA, Bockmeyer CL, Modde F, Wittig J, Heinemann FM, Brundiers S, Dämmrich ME, Schwarz A, Birschmann I, Suwelack B, Jindra PT, Ahlenstiel T, Wohlschläger J, Vester U, Ganzenmüller T, Zilian E, Feldkamp T, Spieker T, Immenschuh S, Kreipe HH, Bröcker V, Becker JU.

Transplantation. 2013 May 27;95(10):1242-8. doi: 10.1097/TP.0b013e318291a298.

PMID:
23635876
3.

Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney.

Xu Y, Hagege J, Mougenot B, Sraer JD, Rønne E, Rondeau E.

Kidney Int. 1996 Dec;50(6):2011-9.

5.

Enhanced expression of plasminogen activator inhibitor 1 in patients with nephrotic syndrome.

Yoshida Y, Shiiki H, Iwano M, Uyama H, Hamano K, Nishino T, Dohi K.

Nephron. 2001 May;88(1):24-9.

PMID:
11340346
6.

Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.

Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ.

J Am Soc Nephrol. 2014 Jan;25(1):55-64. doi: 10.1681/ASN.2013050453. Epub 2013 Sep 12.

7.

Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.

Peyvandi F, Rossio R, Ferrari B, Lotta LA, Pontiggia S, Ghiringhelli Borsa N, Pizzuti M, Donadelli R, Piras R, Cugno M, Noris M.

J Thromb Haemost. 2016 Feb;14(2):340-5. doi: 10.1111/jth.13210. Epub 2016 Feb 1.

PMID:
26613809
8.

Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.

Cataland SR, Wu HM.

Eur J Intern Med. 2013 Sep;24(6):486-91. doi: 10.1016/j.ejim.2013.05.007. Epub 2013 Jun 2. Review.

PMID:
23739653
9.

Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.

Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V.

Blood. 2013 Aug 22;122(8):1487-93. doi: 10.1182/blood-2013-03-492421. Epub 2013 Jul 11.

10.

Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature.

Manenti L, Gnappi E, Vaglio A, Allegri L, Noris M, Bresin E, Pilato FP, Valoti E, Pasquali S, Buzio C.

Nephrol Dial Transplant. 2013 Sep;28(9):2246-59. doi: 10.1093/ndt/gft220. Epub 2013 Jun 19. Review.

PMID:
23787552
11.

Prognostic value of plasminogen activator inhibitor type 1 mRNA in microdissected glomeruli from transplanted kidneys.

Delarue F, Hertig A, Alberti C, Vigneau C, Ammor M, Berrou J, Akposso K, Peraldi MN, Rondeau E, Sraer JD.

Transplantation. 2001 Oct 15;72(7):1256-61.

PMID:
11602852
12.

Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis.

Hamano K, Iwano M, Akai Y, Sato H, Kubo A, Nishitani Y, Uyama H, Yoshida Y, Miyazaki M, Shiiki H, Kohno S, Dohi K.

Am J Kidney Dis. 2002 Apr;39(4):695-705.

PMID:
11920334
13.

How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome.

Cataland SR, Wu HM.

Blood. 2014 Apr 17;123(16):2478-84. doi: 10.1182/blood-2013-11-516237. Epub 2014 Mar 5.

14.

Complement activation in diseases presenting with thrombotic microangiopathy.

Meri S.

Eur J Intern Med. 2013 Sep;24(6):496-502. doi: 10.1016/j.ejim.2013.05.009. Epub 2013 Jun 4. Review.

PMID:
23743117
15.

Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.

Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH.

Am J Reprod Immunol. 2015 Oct;74(4):345-56. doi: 10.1111/aji.12404. Epub 2015 May 24.

PMID:
26011580
16.

A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.

Tsai HM.

Transfus Med Rev. 2014 Oct;28(4):187-97. doi: 10.1016/j.tmrv.2014.08.004. Epub 2014 Sep 3. Review.

PMID:
25280590
17.

Atypical hemolytic uremic syndrome.

Loirat C, Frémeaux-Bacchi V.

Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Review.

18.

Genetics of atypical hemolytic uremic syndrome (aHUS).

Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.

Semin Thromb Hemost. 2014 Jun;40(4):422-30. doi: 10.1055/s-0034-1375296. Epub 2014 May 5. Review.

PMID:
24799305
19.

The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.

Phillips EH, Westwood JP, Brocklebank V, Wong EK, Tellez JO, Marchbank KJ, McGuckin S, Gale DP, Connolly J, Goodship TH, Kavanagh D, Scully MA.

J Thromb Haemost. 2016 Jan;14(1):175-85. doi: 10.1111/jth.13189. Epub 2016 Jan 11.

20.

The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome.

Berger BE.

Am J Med Sci. 2016 Aug;352(2):177-90. doi: 10.1016/j.amjms.2016.05.003. Epub 2016 May 9. Review.

PMID:
27524217

Supplemental Content

Support Center